1.1 Articolo in rivista

1.1 Articolo in rivista: [24022] Home page tipologia

Sfoglia

Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 10.861 a 10.880 di 24.022

Liposomal delivery of a 30-mer antisense oligodeoxynucleotide to inhibit proopiomelanocortin expression

1998-01-01 Fresta, M.; Chillemi, R.; Spampinato, S.; Sciuto, S.; Puglisi, G.

Phospholipid vesicles as a drug delivery system. Part I. Interaction of cytidine-5'-diphosphate choline with charged and zwitterionic phospholipids

1992-01-01 La Rosa, C.; Grasso, D.; Fresta, M.; Ventura, C.; Puglisi, G.

Survival rate improvement in a rat ischemia model by long circulating liposomes containing cytidine-5(I)-diphosphate choline

1997-01-01 Fresta, M.; Puglisi, G.

Solid state characterization and in solution studies of idebenone-β-cyclodextrin inclusion complex

1995-01-01 Ventura, C. A.; Fresta, M.; Giovinazzo, C.; Puglisi, G.

Liposomes as In‐vivo Carriers for Citicoline: Effects on Rat Cerebral Post‐ischaemic Reperfusion

1994-01-01 Fresta, M.; Puglisi, G.; DI GIACOMO, C.; Russo, A.

Ofloxacin-loaded liposomes: In vitro activity and drug accumulation in bacteria

2000-01-01 Furneri, P. M.; Fresta, M.; Puglisi, G.; Tempera, G.

The Rheolaser Master™ and Kinexus rotational rheometer® to evaluate the influence of topical drug delivery systems on rheological features of topical poloxamer gel

2020-01-01 Cristiano, M. C.; Froiio, F.; Mancuso, A.; de Gaetano, F.; Ventura, C. A.; Fresta, M.; Paolino, D.

Encapsulation of neutrase in liposomes for the acceleration of Cheddar cheese ripening

1995-01-01 Fresta, M.

Synthesis and preliminary in vitro screening of lipophilic α,-γ-bis(amides) as potential prodrugs of methotrexate

1996-01-01 Pignatello, R.; Sorrenti, V.; Spampinato, G.; Pecora, T.; Panico, A.; Di Giacomo, C.; Fresta, M.; Vanella, A.; Puglisi, G.

Simultaneous spectrophotometric determination in solid phase of aspirin and its impurity salicylic acid in pharmaceutical formulations

1992-01-01 Villari, A.; Micali, N.; Fresta, M.; Puglisi, G.

Phospholipid vesicles as drug delivery systems. Part II. A study on kinetic fusion between vesicles containing CDP-choline and dipalmitoylphosphatidylcholine vesicles

1992-01-01 La Rosa, C.; Grasso, D.; Fresta, M.; Ventura, C. A.; Puglisi, G.

Design, synthesis and characterization of a PEGylated stanozolol for potential therapeutic applications

2020-01-01 Vergallo, C.; Torrieri, G.; Provenzani, R.; Miettinen, S.; Moslova, K.; Varjosalo, M.; Cristiano, M. C.; Fresta, M.; Celia, C.; Santos, H. A.; Cilurzo, F.; Di Marzio, L.

Preparation and characterization of polyethyl-2-cyanoacrylate nanocapsules containing antiepileptic drugs

1996-01-01 Fresta, M.; Cavallaro, G.; Giammona, G.; Wehrli, E.; Puglisi, G.

Formulation parameters of fluoroquinolone-loaded liposomes and in vitro antimicrobial activity

1995-01-01 Puglisi, G.; Fresta, M.; Mazzone, G.; Furneri, P. M.; Tempera, G.

Erratum: A potent immunomodulatory compound, (S,R)-3-phenyl-4,5-dihydro-5- isoxasole acetic acid, prevents spontaneous and accelerated forms of autoimmune diabetes in NOD mice and inhibits the immunoinflammatory diabetes induced by multiple low doses of streptozotocin in CBA/H mice (Journal of Pharmacology and Experimental Therapeutics (2006) 320, (1038-1049))

2007-01-01 Stosic-Grujicic, S.; Cvetkovic, I.; Mangano, K.; Fresta, M.; Maksimovic-Ivanic, D.; Harhaji, L.; Popadic, D.; Momcilovic, M.; Miljkovic, D.; Kim, J.; Al-Abed, Y.; Nicoletti, F.

In vitro and in vivo trans-epidermal water loss evaluation following topical drug delivery systems application for pharmaceutical analysis

2020-01-01 Cristiano, M. C.; Froiio, F.; Mancuso, A.; Iannone, M.; Fresta, M.; Fiorito, S.; Celia, C.; Paolino, D.

Spectrofluorimetry at zero angle: Determination of salicylic acid in an acetylsalicylic acid pharmaceutical formulation

1994-01-01 Villari, A.; Micali, N.; Fresta, M.; Puglisi, G.

Interaction of natural and modified β-cyclodextrins with a biological membrane model of dipalmitoylphosphatidylcholine

1996-01-01 Puglisi, G.; Fresta, M.; Ventura, C. A.

Preparation and physico-chemical study of inclusion complexes between idebenone and modified β-cyclodextrins

1996-01-01 Puglisi, G.; Ventura, C. A.; Fresta, M.; Vandelli, M. A.; Cavallaro, G.; Zappala, M.

Liposome‐embedding silicon microparticle for oxaliplatin delivery in tumor chemotherapy

2020-01-01 Cevenini, A.; Celia, C.; Orru, S.; Sarnataro, D.; Raia, M.; Mollo, V.; Locatelli, M.; Imperlini, E.; Peluso, N.; Peltrini, R.; De Rosa, E.; Parodi, A.; Del Vecchio, L.; Di Marzio, L.; Fresta, M.; Netti, P. A.; Shen, H.; Liu, X.; Tasciotti, E.; Salvatore, F.

Titolo	Data di pubblicazione	Autore(i)
Liposomal delivery of a 30-mer antisense oligodeoxynucleotide to inhibit proopiomelanocortin expression	1-gen-1998	Fresta, M.; Chillemi, R.; Spampinato, S.; Sciuto, S.; Puglisi, G.
Phospholipid vesicles as a drug delivery system. Part I. Interaction of cytidine-5'-diphosphate choline with charged and zwitterionic phospholipids	1-gen-1992	La Rosa, C.; Grasso, D.; Fresta, M.; Ventura, C.; Puglisi, G.
Survival rate improvement in a rat ischemia model by long circulating liposomes containing cytidine-5(I)-diphosphate choline	1-gen-1997	Fresta, M.; Puglisi, G.
Solid state characterization and in solution studies of idebenone-β-cyclodextrin inclusion complex	1-gen-1995	Ventura, C. A.; Fresta, M.; Giovinazzo, C.; Puglisi, G.
Liposomes as In‐vivo Carriers for Citicoline: Effects on Rat Cerebral Post‐ischaemic Reperfusion	1-gen-1994	Fresta, M.; Puglisi, G.; DI GIACOMO, C.; Russo, A.
Ofloxacin-loaded liposomes: In vitro activity and drug accumulation in bacteria	1-gen-2000	Furneri, P. M.; Fresta, M.; Puglisi, G.; Tempera, G.
The Rheolaser Master™ and Kinexus rotational rheometer® to evaluate the influence of topical drug delivery systems on rheological features of topical poloxamer gel	1-gen-2020	Cristiano, M. C.; Froiio, F.; Mancuso, A.; de Gaetano, F.; Ventura, C. A.; Fresta, M.; Paolino, D.
Encapsulation of neutrase in liposomes for the acceleration of Cheddar cheese ripening	1-gen-1995	Fresta, M.
Synthesis and preliminary in vitro screening of lipophilic α,-γ-bis(amides) as potential prodrugs of methotrexate	1-gen-1996	Pignatello, R.; Sorrenti, V.; Spampinato, G.; Pecora, T.; Panico, A.; Di Giacomo, C.; Fresta, M.; Vanella, A.; Puglisi, G.
Simultaneous spectrophotometric determination in solid phase of aspirin and its impurity salicylic acid in pharmaceutical formulations	1-gen-1992	Villari, A.; Micali, N.; Fresta, M.; Puglisi, G.
Phospholipid vesicles as drug delivery systems. Part II. A study on kinetic fusion between vesicles containing CDP-choline and dipalmitoylphosphatidylcholine vesicles	1-gen-1992	La Rosa, C.; Grasso, D.; Fresta, M.; Ventura, C. A.; Puglisi, G.
Design, synthesis and characterization of a PEGylated stanozolol for potential therapeutic applications	1-gen-2020	Vergallo, C.; Torrieri, G.; Provenzani, R.; Miettinen, S.; Moslova, K.; Varjosalo, M.; Cristiano, M. C.; Fresta, M.; Celia, C.; Santos, H. A.; Cilurzo, F.; Di Marzio, L.
Preparation and characterization of polyethyl-2-cyanoacrylate nanocapsules containing antiepileptic drugs	1-gen-1996	Fresta, M.; Cavallaro, G.; Giammona, G.; Wehrli, E.; Puglisi, G.
Formulation parameters of fluoroquinolone-loaded liposomes and in vitro antimicrobial activity	1-gen-1995	Puglisi, G.; Fresta, M.; Mazzone, G.; Furneri, P. M.; Tempera, G.
Erratum: A potent immunomodulatory compound, (S,R)-3-phenyl-4,5-dihydro-5- isoxasole acetic acid, prevents spontaneous and accelerated forms of autoimmune diabetes in NOD mice and inhibits the immunoinflammatory diabetes induced by multiple low doses of streptozotocin in CBA/H mice (Journal of Pharmacology and Experimental Therapeutics (2006) 320, (1038-1049))	1-gen-2007	Stosic-Grujicic, S.; Cvetkovic, I.; Mangano, K.; Fresta, M.; Maksimovic-Ivanic, D.; Harhaji, L.; Popadic, D.; Momcilovic, M.; Miljkovic, D.; Kim, J.; Al-Abed, Y.; Nicoletti, F.
In vitro and in vivo trans-epidermal water loss evaluation following topical drug delivery systems application for pharmaceutical analysis	1-gen-2020	Cristiano, M. C.; Froiio, F.; Mancuso, A.; Iannone, M.; Fresta, M.; Fiorito, S.; Celia, C.; Paolino, D.
Spectrofluorimetry at zero angle: Determination of salicylic acid in an acetylsalicylic acid pharmaceutical formulation	1-gen-1994	Villari, A.; Micali, N.; Fresta, M.; Puglisi, G.
Interaction of natural and modified β-cyclodextrins with a biological membrane model of dipalmitoylphosphatidylcholine	1-gen-1996	Puglisi, G.; Fresta, M.; Ventura, C. A.
Preparation and physico-chemical study of inclusion complexes between idebenone and modified β-cyclodextrins	1-gen-1996	Puglisi, G.; Ventura, C. A.; Fresta, M.; Vandelli, M. A.; Cavallaro, G.; Zappala, M.
Liposome‐embedding silicon microparticle for oxaliplatin delivery in tumor chemotherapy	1-gen-2020	Cevenini, A.; Celia, C.; Orru, S.; Sarnataro, D.; Raia, M.; Mollo, V.; Locatelli, M.; Imperlini, E.; Peluso, N.; Peltrini, R.; De Rosa, E.; Parodi, A.; Del Vecchio, L.; Di Marzio, L.; Fresta, M.; Netti, P. A.; Shen, H.; Liu, X.; Tasciotti, E.; Salvatore, F.

Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 10.861 a 10.880 di 24.022

Legenda icone

file ad accesso aperto
file disponibili sulla rete interna
file disponibili agli utenti autorizzati
file disponibili solo agli amministratori
file sotto embargo
nessun file disponibile

Scopri

Accesso al fulltext

no fulltext23986
reserved26
open10